This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Cyclacel Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Benjamin Skead
Introduction
Benjamin Skead is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with potential therapeutic applications. With a total of 2 patents to his name, Skead's work focuses on innovative processes and formulations that could lead to advancements in medical treatments.
Latest Patents
Skead's latest patents include a process for the preparation of a pyrimidino-diazepine derivative. This invention outlines a method that involves treating a specific compound with N-methylpiperazine, followed by a series of steps to isolate the desired trans-isomer. Additionally, he has developed new crystalline forms of a pyrimido-diazepine derivative that exhibit excellent anti-tumor activity. These inventions not only highlight his expertise in chemical processes but also his commitment to addressing critical health challenges.
Career Highlights
Benjamin Skead is currently associated with Cyclacel Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work has the potential to contribute significantly to the development of new treatments for various diseases, showcasing his dedication to improving patient outcomes.
Collaborations
Skead collaborates with talented individuals such as Chris Atherton and Julian Northen. These partnerships enhance the innovative capacity of his projects and foster a collaborative environment that is essential for scientific advancement.
Conclusion
In summary, Benjamin Skead's contributions to the field of pharmaceuticals through his patents and collaborative efforts position him as a key figure in the ongoing quest for innovative medical solutions. His work exemplifies the impact that dedicated inventors can have on healthcare advancements.